| Date Filed | Type | Description |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/28/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 704,595 shares
@ $0.5015, valued at
$353.4k
Sold 56,242 shares
@ $0.4536, valued at
$25.5k
Sold 333,010 shares
@ $0.4387, valued at
$146.1k
|
|
| 10/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 142,857 shares
@ $0.7, valued at
$100k
|
|
| 03/14/2019 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 142,857 shares
@ $0.7, valued at
$100k
|
|
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/17/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $1.1888, valued at
$89.2k
Bought 75,000 shares
@ $1.23, valued at
$92.3k
Bought 60,000 shares
@ $1.1824, valued at
$70.9k
|
|
| 09/17/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $1.1888, valued at
$89.2k
Bought 75,000 shares
@ $1.23, valued at
$92.3k
Bought 60,000 shares
@ $1.1824, valued at
$70.9k
|
|
| 09/12/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 200,000 shares
@ $1.2182, valued at
$243.6k
Bought 200,000 shares
@ $1.1442, valued at
$228.8k
Bought 75,000 shares
@ $1.1455, valued at
$85.9k
|
|
| 09/12/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 200,000 shares
@ $1.2182, valued at
$243.6k
Bought 200,000 shares
@ $1.1442, valued at
$228.8k
Bought 75,000 shares
@ $1.1455, valued at
$85.9k
|
|
| 09/07/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8465, valued at
$42.3k
Bought 50,000 shares
@ $0.8419, valued at
$42.1k
Bought 60,000 shares
@ $0.8957, valued at
$53.7k
|
|
| 09/07/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8465, valued at
$42.3k
Bought 50,000 shares
@ $0.8419, valued at
$42.1k
Bought 60,000 shares
@ $0.8957, valued at
$53.7k
|
|
| 08/16/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 190,977 shares
@ $0.6486, valued at
$123.9k
Bought 272,000 shares
@ $0.6467, valued at
$175.9k
Bought 66,393 shares
@ $0.6493, valued at
$43.1k
|
|
| 08/16/2018 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 190,977 shares
@ $0.6486, valued at
$123.9k
Bought 272,000 shares
@ $0.6467, valued at
$175.9k
Bought 66,393 shares
@ $0.6493, valued at
$43.1k
|
|
| 08/16/2018 |
3
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
| 08/16/2018 |
3
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| VENROCK ASSOCIATES IV L P reports a 5% stake in Quantenna Communications, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/27/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/16/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/05/2015 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/20/2015 |
SC 13D/A
| VENROCK ASSOCIATES IV L P reports a 3.8% stake in Anacor Pharmaceuticals Inc. |
| 02/13/2015 |
SC 13G
| VENROCK ASSOCIATES IV L P reports a 9.8% stake in ACHAOGEN, INC. |
| 02/13/2015 |
SC 13G/A
| VENROCK ASSOCIATES IV L P reports a 4.6% stake in ACCELERON PHARMA INC. |
| 03/17/2014 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Achaogen Inc|
Txns:
| Converted 340,797 shares
@ $0
Converted 296,878 shares
@ $0
Converted 725,873 shares
@ $0
Converted 382,913 shares
@ $0
Converted 296,981 preferred shares
@ $0
Converted 223,440 preferred shares
@ $0
Converted 725,873 preferred shares
@ $0
Converted 382,913 preferred shares
@ $0 |
|
| 02/14/2014 |
SC 13G
| VENROCK ASSOCIATES IV L P reports a 9.2% stake in ACCELERON PHARMA INC. |
| 11/19/2013 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Sold 150,000 shares
@ $14.06, valued at
$2.1M
|
|
| 03/15/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/24/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 19,273 shares
@ $6.3019, valued at
$121.5k
|
|
| 09/18/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 35,000 shares
@ $6.5087, valued at
$227.8k
|
|
| 09/13/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 10,177 shares
@ $6.6427, valued at
$67.6k
Sold 15,000 shares
@ $6.5553, valued at
$98.3k
|
|
| 07/05/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Disposed of 900,000 shares
@ $0
Acquired 79,450 shares
@ $0 |
|
|